Bell David, Allen Adrian R, Kelso Elizabeth J, Balasubramaniam Ambikaipakan, McDermott Barbara J
Department of Therapeutics and Pharmacology, Centre for Cardiovascular and Genetics Research, School of Medicine, The Queen's University of Belfast, Whitla Medical Building, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, UK.
J Pharmacol Exp Ther. 2002 Nov;303(2):581-91. doi: 10.1124/jpet.102.038448.
To determine whether neuropeptide Y (NPY)-related mechanisms become activated with progression of cardiac hypertrophy in vivo, protein mass and de novo protein synthesis (incorporation of [(14)C]Phe, 0.1 muCi ml(-1)) were assessed in cardiomyocytes, obtained from spontaneously hypertensive rats (SHRs) and normotensive Wistar Kyoto rats (8, 12, 16, 20, and 24 weeks of age), and cultured for 24 h. NPY (10(-8) M) increased protein mass of cardiomyocytes from 16-week-old SHRs by 9.2 +/- 2.1% (n = 8, P < 0.05). De novo protein synthesis was increased maximally in SHRs at 12, 16, and 20 weeks (P < 0.05, n = 8) in response to NPY by 12.6 +/- 2.1% (10(-6) M), 20.1 +/- 4.2% (10(-8) M), and 9.4 +/- 1.8% (10(-7) M), respectively. Peptide YY(3-36), (PYY(3-36)), which displays selectivity for NPY Y(2) and NPY Y(5) receptors, and the NPY Y(5)-selective agonist [D-Trp(34)]-NPY increased de novo protein synthesis maximally by 16.2 +/- 5.1% (10(-7) M; n = 4, P < 0.05) and 17.8 +/- 5.2% (10(-6) M; n = 7, P < 0.05), respectively, in SHRs at 16 weeks, whereas [Leu(31)Pro(34)]-NPY (< or =10(-6) M), which displays some activity at NPY Y(1) and NPY Y(4) receptors, did not. The NPY Y(1)-selective antagonist BVD-42 (2 x 10(-7) M) and the NPY Y(2)-selective antagonist BIIE0246 (2 x 10(-7) M) did not attenuate responses to NPY (10(-7) M) and PPY(3-36) (10(-7) M). These data indicate that hypertrophic responsiveness to NPY, mediated via NPY Y(5) receptors, is induced transiently in SHR cardiomyocytes subsequent to onset of cardiomyocyte hypertrophy in response to pressure overload.
为了确定体内心肌肥厚进展过程中神经肽Y(NPY)相关机制是否被激活,我们评估了从自发性高血压大鼠(SHR)和正常血压的Wistar Kyoto大鼠(8、12、16、20和24周龄)分离并培养24小时的心肌细胞中的蛋白质含量和从头蛋白质合成(掺入[(14)C]苯丙氨酸,0.1μCi/ml)。NPY(10(-8)M)使16周龄SHR的心肌细胞蛋白质含量增加了9.2±2.1%(n = 8,P < 0.05)。在12、16和20周龄的SHR中,从头蛋白质合成对NPY的反应最大程度增加(P < 0.05,n = 8),分别增加了12.6±2.1%(10(-6)M)、20.1±4.2%(10(-8)M)和9.4±1.8%(10(-7)M)。对NPY Y(2)和NPY Y(5)受体具有选择性的肽YY(3-36)(PYY(3-36))以及NPY Y(5)选择性激动剂[D-Trp(34)]-NPY在第16周龄的SHR中分别使从头蛋白质合成最大程度增加了16.2±5.1%(10(-7)M;n = 4,P < 0.05)和17.8±5.2%(10(-6)M;n = 7,P < 0.05),而对NPY Y(1)和NPY Y(4)受体有一定活性的[Leu(31)Pro(34)]-NPY(≤10(-6)M)则没有这种作用。NPY Y(1)选择性拮抗剂BVD-42(2×10(-7)M)和NPY Y(2)选择性拮抗剂BIIE0246(2×10(-7)M)并未减弱对NPY(10(-7)M)和PPY(3-36)(10(-7)M)的反应。这些数据表明压力超负荷导致心肌细胞肥大后,SHR心肌细胞中通过NPY Y(5)受体介导的对NPY的肥厚反应性会短暂诱导产生。